EU/3/18/2031: Orphan designation for the treatment of perinatal asphyxia
Table of contents
On 27 June 2018, orphan designation (EU/3/18/2031) was granted by the European Commission to Air Liquide Santé (International), France, for argon for the treatment of perinatal asphyxia.
Treatment of perinatal asphyxia
|Orphan designation status||
|EU designation number||
|Date of designation||
Air Liquide Santé (International)
75 quai d’Orsay
Tel. +33 1 49 69 82 00
Review of designation
The Committee for Orphan Medicinal Products reviews the orphan designation of a product if it is approved for marketing authorisation.
Documents related to this orphan designation evaluation
For contact details of patients’ organisations whose activities are targeted at rare diseases, see:
Orphanet, a database containing information on rare diseases, which includes a directory of patients’ organisations registered in Europe.
European Organisation for Rare Diseases (EURORDIS), a non-governmental alliance of patient organisations and individuals active in the field of rare diseases.
EU register of orphan medicines
The list of medicines that have received an orphan designation in the EU is available on the European Commission's website: